Literature DB >> 23695007

[Vascular factors in the pathogenesis of Alzheimer's disease].

C Lange-Asschenfeldt.   

Abstract

According to the amyloid hypothesis of Alzheimer's disease (AD), the amyloid β (Aβ) peptide, as the primary neurotoxic species, plays a key role in the pathogenesis of the disease. However, many lines of recent evidence also point towards a major importance of early cerebrovascular dysfunction at least for the most common form of the disease, sporadic AD. In the preclinical course not only neuronal but also vascular damage frequently occurs. Cerebral hypoperfusion, blood-brain barrier dysfunction and vascular oxidative stress are typical features of this stage of the disease. Most importantly, such alterations precede the classical pathological hallmarks, such as parenchymal deposition of extracellular amyloid and intracellular neurofibrillary tangles. In this article recent epidemiological, clinical pathological and experimental evidence for an integrative vascular neuronal pathogenetic model of sporadic AD is reviewed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23695007     DOI: 10.1007/s00115-013-3800-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  35 in total

Review 1.  The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia.

Authors:  Costantino Iadecola
Journal:  Acta Neuropathol       Date:  2010-07-11       Impact factor: 17.088

2.  Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.

Authors:  Joshua B Owen; Rukhsana Sultana; Christopher D Aluise; Michelle A Erickson; Tulin O Price; Guojun Bu; William A Banks; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2010-10-07       Impact factor: 7.376

Review 3.  Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease.

Authors:  Karl Herholz
Journal:  Expert Rev Neurother       Date:  2010-11       Impact factor: 4.618

Review 4.  Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies.

Authors:  Behnam Sabayan; Steffy Jansen; Anna M Oleksik; Matthias J P van Osch; Mark A van Buchem; Peter van Vliet; Anton J M de Craen; Rudi G J Westendorp
Journal:  Ageing Res Rev       Date:  2011-12-27       Impact factor: 10.895

Review 5.  Cerebral autoregulation in Alzheimer's disease.

Authors:  Jurgen A H R Claassen; Rong Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-04       Impact factor: 6.200

Review 6.  Vascular oxidative stress in Alzheimer disease.

Authors:  Xiongwei Zhu; Mark A Smith; Kazuhiro Honda; Gjumrakch Aliev; Paula I Moreira; Akihiko Nunomura; Gemma Casadesus; Peggy L R Harris; Sandra L Siedlak; George Perry
Journal:  J Neurol Sci       Date:  2007-03-06       Impact factor: 3.181

7.  Long-term incubation with beta-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery.

Authors:  Mariangela Chisari; Sara Merlo; Maria Angela Sortino; Salvatore Salomone
Journal:  Pharmacol Res       Date:  2009-09-24       Impact factor: 7.658

8.  Stroke and the risk of Alzheimer disease.

Authors:  Lawrence S Honig; Ming-Xin Tang; Steven Albert; Rosanne Costa; Jose Luchsinger; Jennifer Manly; Yaakov Stern; Richard Mayeux
Journal:  Arch Neurol       Date:  2003-12

9.  Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.

Authors:  Mark Yarchoan; Sharon X Xie; Mitchel A Kling; Jon B Toledo; David A Wolk; Edward B Lee; Vivianna Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Steven E Arnold
Journal:  Brain       Date:  2012-11-30       Impact factor: 13.501

Review 10.  Alzheimer's disease: the two-hit hypothesis.

Authors:  Xiongwei Zhu; Arun K Raina; George Perry; Mark A Smith
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

View more
  1 in total

1.  [Neurocognitive disorders in DSM-5: pervasive changes in the diagnostics of dementia].

Authors:  W Maier; U B Barnikol
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.